0.5665USD+5.63%Mkt Cap: 55.57M USDP/E: —Last update: 2026-06-01
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the Uni…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap55.57M USD
Enterprise Value-1.81M USD
Revenue (TTM)190.00K USD
Gross Profit-55.53M USD
Net Income (TTM)-74.12M USD
Revenue/Share0.0020 USD
Last Price0.5665 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees58
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.85
PEG—
EV/EBITDA0.03
EV/Revenue-9.54
P/S279.96
P/B0.92
EPS (TTM)-0.74
EPS (Forward)-0.64
52W Range
0.39502% of range7.290
52W High7.290 USD
52W Low0.3950 USD
Profitability
Gross Margin0.00%
Oper. Margin-38573.68%
EBITDA Margin0.00%
Profit Margin-39009.47%
ROE-109.84%
ROA-79.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-61.99M USD
CapEx (TTM)77.00K USD
FCF Margin-17185.39%
FCF Yield-58.76%
Net Debt-54.81M USD
Net Debt/EBITDA0.75
Balance Sheet
Debt/Equity0.18
Current Ratio5.78
Quick Ratio5.73
Book Value/Sh0.5910 USD
Cash/Share0.6780 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJul 1, 2019
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)2.857 USD
Target Range1.000 USD – 7.000 USD
# Analysts7
Ownership
Shares Out.98.05M
Float95.61M
Insiders2.45%
Institutions57.51%
Short Interest
Short Ratio7.8d
Short % Float25.14%
Short % Out.21.82%
Shares Short21.39M
Short (prev mo.)19.88M
Technical
SMA 500.7485 (-24.3%)
SMA 2001.330 (-57.4%)
Beta0.66
S&P 52W Chg27.94%
Avg Vol (30d)3.11M
Avg Vol (10d)4.94M
Technical Indicators
RSI (14)41.9
MACD-0.0856
MACD Signal-0.0798
MACD Hist.-0.0058
BB Upper1.059 USD
BB Middle0.6463 USD
BB Lower0.2336 USD
BB Width127.70%
ATR (14)0.0749 USD
Vol Ratio (20d)1.21x